2nd Annual Jefferson Health Cardio-Oncology Summit

Saturday, May 9, 2026, 7:30 AM - 1:00 PM, Dorrance H. Hamilton Building, Philadelphia, PA


AMA PRA Category 1 Credits™ (4.75 hours), ABS CC (4.75 hours), ACPE Contact Hour(s) (4.75 hours), ANCC Contact Hour(s) (4.75 hours), Non-Physician Attendance (4.75 hours)

This educational activity provides a comprehensive introduction to the rapidly evolving field of cardio-oncology, drawing on the expertise and resources of Jefferson Health’s Enterprise Cardio-Oncology Program and the Bruce and Robbi Toll Heart & Vascular Institute.

Participants will learn evidence-based strategies for evaluating and managing cardiovascular health in patients undergoing cancer treatment, as well as best practices for supporting long-term survivorship. Through presentations from leading local experts, the course explores the full spectrum of cardiovascular complications associated with cancer therapies and equips clinicians with practical tools to identify high-risk patients, interpret diagnostic data, and implement effective monitoring and prevention strategies.

Louis R. Dinon, MD Memorial Lecture in Clinical Cardiology Keynote
Susan Dent, MD, FRCPC, FICOS

Dr. Susan Dent completed her medical training at McMaster University and the University of Ottawa, followed by a clinical trials research fellowship with the Canadian Cancer Trials Group. She began her career as a staff medical oncologist in Thunder Bay before returning to Ottawa in 2001 to focus on breast cancer. There, she helped establish Canada’s first multidisciplinary cardio-oncology clinic in 2008 and later founded the Canadian Cardiac Oncology Network to advance cancer care without compromising cardiovascular health.

Her career then expanded to academic leadership roles at Duke University, where she served as Professor of Medicine and held key positions in breast cancer research and cardio-oncology. In September 2024, she joined the Wilmot Cancer Institute at the University of Rochester as Director of the Cardio-Oncology Program and Director of the Judy DiMarzo Cancer Institute Survivorship Program, continuing her work at the intersection of cancer treatment and heart health. Dr. Dent  is also the Immediate Past President International Cardio-Oncology Society.

---

Successful Completion
To successfully complete this activity, the required evaluation must be completed no later than Friday, May 29, 2026. Thereafter, the evaluation will no longer be available and credits will not be issued. No refunds will be offered for failure to complete the required evaluation by the stated deadline.

1. Define the spectrum of cardiovascular complications from cancer treatments.
2. Recognize mechanisms of cardiotoxicity across different therapeutic classes.
3. Identify high-risk patients before initiating cancer therapy.
4. Apply cardiovascular risk assessment tools in cancer populations.
5. Implement evidence-based surveillance strategies.
6. Interpret cardiac imaging and biomarkers in the oncology setting.
7. Recognize and manage acute cardiovascular conditions and complications.
8. Balance cancer treatment continuation with cardiovascular safety.
9. Outline cancer therapies’ potential impact on the cardiovascular system.
10. Optimize cardiovascular risk factors to prevent cancer treatment interruption.
11. Define cardiovascular risk in cancer survivorship.

	Jefferson In Person	Jefferson Virtual	Non-Jefferson In Person	Non-Jefferson Virtual
Physician	$0	$0	$100	$125
Nurse/Nurse Practitioner	$0	$0	$100	$125
Pharmacist	$0	$0	$100	$125
Other Healthcare Provider	$0	$0	$100	$125
Resident/Fellow	$0	$0	$0	$0

In support of improving patient care, Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians: This educational activity is designated for a maximum of 4.75 AMA PRA Category 1 Credits ^TM . Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses: This activity awards 4.75 nursing contact hours.

Pharmacists: This knowledge-based continuing education is designated for 4.75 credit contact hours of continuing education credit. JA#
Credits will be uploaded to CPE Monitor within 60 days following the completion of the activity. This statement contains information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner's e-profile in CPE Monitor.

Other Healthcare Professionals: This educational activity is designated for 4.75 AMA PRA Category 1 Credit ^TM. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Agenda
Agenda subject to change without notice.

Cancellation Policy
Requests for refunds must be submitted in writing and received in the Office of CPD two weeks prior to the start date of the course. There will be no refunds after this period.*  Cancellations notified before the two week time frame will incur a 25% administration fee (with a minimum of $20).  Registrants who fail to attend the conference are responsible for the entire fee.  All refunds will be processed after the conference.  The University reserves the right to cancel or postpone this course due to unforeseen circumstances.  In the event of cancellation or postponement, the University will refund registration fees, but is not responsible for related costs or expenses to participants, including cancellation fees assessed by hotels, airlines or travel agencies. Registration fees will be refunded less a 15% administration fee to international conference registrants who are unable to secure a travel visa. Registrants must provide proof of visa denial. Email [email protected] - please include the activity name in the subject line. 

Jefferson Release Policy
Jefferson may record/livestream/photograph this educational activity. These images/recordings, along with your name, may be used in Jefferson publications or on the Jefferson website. If you verbally submit any questions for Q&A sessions, you are agreeing to be recorded and to have that recording available in enduring materials. Once photographed, filmed, recorded, or videotaped, you waive the right of inspection or approval to which such images/recordings may be put and Jefferson has the right to use, publish, reproduce, modify, adapt, and distribute at any time in any manner or medium.

Jefferson HIPAA Policy
As an attendee of this educational activity hosted by Thomas Jefferson University, Jefferson University Physicians, and Thomas Jefferson University Hospitals, Inc. (collectively 'Jefferson'), you may gain access to certain proprietary information ('Confidential Information'), including Protected Health Information ('PHI').

By participating in this educational activity, you agree to maintain the confidentiality of all Confidential Information, including all PHI, obtained from any source. You also agree to take all necessary steps to protect such Confidential Information and shall not directly or indirectly disclose or use it in any manner or for any reason, other than as necessary to complete the educational activity. Further, you agree not to take photographs, record in any manner or otherwise reproduce any such Confidential Information. You understand that any unauthorized use or disclosure of Confidential Information may result in possible legal action against you by Jefferson whose confidentiality is breached.

Photography and Recording
Unauthorized recording or photography at a Jefferson-sponsored event is strictly prohibited. Individuals found violating this policy will be asked to vacate the activity. No credits or refund will be issued.

Copyright
All rights reserved – Thomas Jefferson University. No part of this program may be used, reproduced, or shared in any manner whatsoever without express written permission, except in the case of brief quotations embodied in articles or reviews.

Dorrance H. Hamilton Building
1001 Locust Street
Philadelphia, PA 19107

Directions
Parking

---

The login information will be available on the Course tab and emailed prior to the start of the activity.

Mitigation of Relevant Financial Relationships

Thomas Jefferson University adheres to the Standards for Integrity and Independence in Accredited Continuing Education and the policies that supplement the Standards.

All planners, faculty, and others in control of educational content are required to disclose any relevant financial relationships with ACCME defined ineligible companies within the past 24 months. Any conflicts of interests have been mitigated prior to this educational activity. Such disclosures will be available prior to the start of the activity. Jefferson conflict of interest mitigation process may result in changes to the program agenda.

Off-Label/Investigational Use
All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the U.S. FDA for the treatment of disease(s).

Content Disclaimer
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.

It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.

Saturday, May 9, 2026

This educational activity received no commercial or in-kind support.

Designed by Jefferson Health’s Cardio-Oncology department, this conference offers a prime opportunity for organizations to connect directly with Jefferson oncology professionals.

Featuring contributions from physicians at Sidney Kimmel Comprehensive Cancer Center and the Lehigh Valley Topper Cancer Institute. As an exhibitor at this event, you will have the opportunity to personally share your product information with approximately 75 physicians and clinical teams seeking the latest innovations that support cancer care, patient management, and clinical research.

Application Deadline
Applications for exhibiting will be accepted through April 24, 2026. After April 24, 2026, applications may be accepted on a case by case basis.

---

Exhibitor Rules

• Exhibitor is not providing commercial support for this activity; they are purchasing exhibit space only.

• All exhibits must be tabletop or portable in nature.

• Exhibitor activities are restricted to the designated space at the conference. Distribution of educational/promotional materials by the exhibitors is limited to their booth space in the exhibit area. It is not permitted anywhere else in the hall, conference meeting space, or at the entrances to the conference meeting space.

• Exhibits are intended for informational purposes only; products should not be sold onsite.

• Photography by exhibitors that include images of the conference or its attendees is prohibited.

• The purpose of the exhibit is to support attendee education through product and service displays and demonstrations. Exhibitor personnel may observe scientific sessions but may not participate in or record them on behalf of their company.

• Thomas Jefferson University is not responsible for the security of exhibitors’ materials. Exhibitors are advised not to leave valuables (e.g., laptops, cell phones) unattended at any time.

Cancellation by Conference Organizers
If the conference is cancelled, the organizers are not responsible for any airfare, hotel, or other costs incurred by exhibitors. The full exhibit fee paid by the company will be refunded.

Exhibitor Refund Request
Requests for exhibitor fee refunds must be submitted in writing and received by the Office of Continuing Professional Development (OCPD) at least one month before the conference start date. Cancellations received before this deadline will incur a 10% cancellation fee. No refunds will be issued after this period. All refunds will be processed after the conference.

Exhibitors who do not attend the conference will not receive a refund. Send refund request to [email protected]. Include conference name in the subject line.

Exhibit at this Event